TABLE 2.
Cell type | 48 h |
72 h |
||||
---|---|---|---|---|---|---|
CC50 (μM) | IC50 egress (μM) | SI50 egress | CC50 (μM) | IC50 egress (μM) | SI50 egress | |
HeLa | 0.49 | 0.042 | 11.7 | 0.39 | 0.003 | 130 |
Human macrophages | 4.8 | 0.18 | 26.7 | 4.2 | 0.055 | 76.4 |
Cytotoxic properties of FC-10696 were tested in either HeLa cells or human macrophages using a CellTiter-Glo kit 48 or 72 h after treatment to select nontoxic concentration range for antiviral tests. In the virus tests, cells were challenged with MARV at an MOI of 0.01 for 1 h and then incubated with new medium containing serially diluted concentrations of FC-10696. To assess virus egress, cell supernatants were titrated on Vero cells. Infected cells were detected by staining with anti-MARV VLP antibody, and nuclei were stained with Hoechst dye. Samples were subsequently imaged and analyzed. The concentration that reduced cell viability by 50% (CC50) and the half-maximal inhibitory concentration (IC50) for virus egress were determined by nonlinear regression analysis. The selectivity index (SI50) was calculated as CC50/IC50.